Scientific Reports · 2015 · 39 citations · 25 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyHemostasisMolecular PharmacologyPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyThrombosisThrombosis PreventionCardioprotective TherapyCollagen-induced Platelet AggregationPlatelet Aggregation InhibitionPlatelet Function ModulationPlatelet Granule SecretionPlatelet InhibitionPlatelet Thrombus FormationThrombin Inhibition
Flavonoids exert both anti-oxidant and anti-platelet activities in vitro and in vivo. Pentamethylquercetin (PMQ), a polymethoxylated flavone derivative, has been screened for anti-carcinogenic and cardioprotective effects. However, it is unclear whether PMQ has anti-thrombotic effects. In the present study, PMQ (20 mg/kg) significantly inhibited thrombus formation in the collagen- epinephrine- induced acute pulmonary thrombosis mouse model and the ferric chloride-induced carotid injury model. To explore the mechanism, we evaluated the effects of PMQ on platelet function. We found that PMQ inhibited platelet aggregation and granule secretion induced by low dose agonists, including ADP, collagen, thrombin and U46619. Biochemical analysis revealed that PMQ inhibited collagen-, thrombin- and U46619-induced activation of Syk, PLCγ2, Akt, GSK3β and Erk1/2. Therefore, we provide the first report to show that PMQ possesses anti-thrombotic activity in vivo and inhibited platelet function in vitro, suggesting that PMQ may represent a potential therapeutic candidate for the prevention or treatment of thrombotic disorders.
25
Klaus‐Peter Janssen, R.P. Mensink, FJ Cox et al. · American Journal of Clinical Nutrition · 1998 · 267 citations · Full text
Impaired platelet responses to thrombin and collagen in AKT-1–deficient mice
Juhua Chen, Sarmishtha De, Derek S. Damron et al. · Blood · 2004 · 238 citations · Full text
Wai Mun Loke, Julie M. Proudfoot, Scott G. Stewart et al. · Biochemical Pharmacology · 2007 · 167 citations